Clinical trial

Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis

NCT00432900 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed

Key facts

NCT number NCT00432900
Title Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
Official title PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients With Multiple Sclerosis (MS)
Lead sponsor National Institute of Neurological Disorders and Stroke (NINDS), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Multiple Sclerosis
Intervention type Radiation
Interventions [(11)C]PBR28
Enrollment 21
Start date Feb 5, 2007
Primary completion May 23, 2013
Completion May 29, 2013
First posted Feb 8, 2007
Last update posted Dec 12, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies